Daptomycin recall: Sterility Concern
DAPTOMYCIN (a)360MG in NS 18ML syringe (b)580MG IN NS 29ML syringe(c) 630MG IN NS 31.5ML used with a home pump; antibiotic, Rx only, Sentara Home…
Why was Daptomycin recalled?
Lack of sterility assurance
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Beyond Use Date: December 25-30, 2022
- Product
- DAPTOMYCIN (a)360MG in NS 18ML syringe (b)580MG IN NS 29ML syringe(c) 630MG IN NS 31.5ML used with a home pump; antibiotic, Rx only, Sentara Home…
- Recalling firm
- Sentara Infusion Services
- Quantity
- 17 bags
- Distribution
- Dispensed to Patients Nationwide.
- Recall date
- February 22, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)